Data and document sharing pose significant challenges, even for well-established Life Sciences companies. Conflicting regulatory guidelines, legacy data sets, countless global registries, insufficient resources dedicated to disclosure, and complex lifecycle management processes are just a few of the obstacles that make it easy to miss important sharing deadlines.
De-Identification Services provided by d-wise help sponsors meet regulatory guidelines for public disclosure and internal sharing to confidently and consistently share on any scale. Available on-demand and without investment into additional software or internal resources, the transparency experts at d-wise will anonymize and measure risk for data sets and clinical study reports and can provide redaction services when necessary.
